$CYCN
Cyclerion Therapeutics, Inc.

2021 Q1 Form 10-K Financial Statement

#000156459021008434 Filed on February 25, 2021

View on sec.gov

Income Statement

Concept 2021 Q1 2020 Q4 2019 Q4
Revenue $62.00K $130.0K $1.480M
YoY Change -93.89% -91.22%
Cost Of Revenue
YoY Change
Gross Profit
YoY Change
Gross Profit Margin
Selling, General & Admin $5.370M $7.270M $7.390M
YoY Change -22.06% -1.62% -12.54%
% of Gross Profit
Research & Development $8.092M $12.09M $20.68M
YoY Change -51.9% -41.54% -7.88%
% of Gross Profit
Depreciation & Amortization $260.0K $470.0K $650.0K
YoY Change -58.73% -27.69% 38.3%
% of Gross Profit
Operating Expenses $13.46M $19.36M $28.07M
YoY Change -37.71% -31.03% -9.16%
Operating Profit -$13.40M
YoY Change -34.94%
Interest Expense $0.00 $0.00 $530.0K
YoY Change -100.0% -100.0%
% of Operating Profit
Other Income/Expense, Net -$4.000K $0.00
YoY Change -101.11%
Pretax Income -$13.40M -$19.23M -$26.06M
YoY Change -33.76% -26.21% -15.66%
Income Tax
% Of Pretax Income
Net Earnings -$13.40M -$19.23M -$26.06M
YoY Change -33.76% -26.21% -15.66%
Net Earnings / Revenue -21611.29% -14792.31% -1760.81%
Basic Earnings Per Share
Diluted Earnings Per Share -$393.2K -$565.3K -$951.8K
COMMON SHARES
Basic Shares Outstanding 34.05M 33.96M
Diluted Shares Outstanding

Balance Sheet

Concept 2021 Q1 2020 Q4 2019 Q4
SHORT-TERM ASSETS
Cash & Short-Term Investments $41.40M $54.40M $94.90M
YoY Change -38.3% -42.68%
Cash & Equivalents $41.43M $54.40M $94.90M
Short-Term Investments
Other Short-Term Assets $1.804M $3.163M $2.862M
YoY Change -9.8% 10.52% 218.0%
Inventory
Prepaid Expenses $1.213M $816.0K $1.966M
Receivables $0.00 $0.00 $1.500M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $44.45M $58.50M $101.2M
YoY Change -36.6% -42.19% 11144.11%
LONG-TERM ASSETS
Property, Plant & Equipment $65.00K $6.865M $11.61M
YoY Change -99.9% -40.89% 78.66%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets $2.681M $2.773M $540.0K
YoY Change -56.05% 413.52%
Total Long-Term Assets $55.52M $56.88M $85.28M
YoY Change -20.57% -33.31% 1212.02%
TOTAL ASSETS
Total Short-Term Assets $44.45M $58.50M $101.2M
Total Long-Term Assets $55.52M $56.88M $85.28M
Total Assets $99.97M $115.4M $186.5M
YoY Change -28.6% -38.13% 2419.97%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $1.095M $1.149M $3.230M
YoY Change -27.0% -64.43% 15.36%
Accrued Expenses $8.500M $11.80M $14.50M
YoY Change -7.61% -18.62% 1.4%
Deferred Revenue
YoY Change
Short-Term Debt $3.500M $3.500M $0.00
YoY Change
Long-Term Debt Due
YoY Change
Total Short-Term Liabilities $13.47M $16.95M $18.25M
YoY Change 18.13% -7.11% 2.52%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $0.00 $0.00
YoY Change
Other Long-Term Liabilities $38.10M $38.90M $70.50M
YoY Change -19.11% -44.82%
Total Long-Term Liabilities $38.10M $38.90M $70.50M
YoY Change -19.11% -44.82%
TOTAL LIABILITIES
Total Short-Term Liabilities $13.47M $16.95M $18.25M
Total Long-Term Liabilities $38.10M $38.90M $70.50M
Total Liabilities $51.50M $55.90M $88.70M
YoY Change -11.97% -36.98% 398.31%
SHAREHOLDERS EQUITY
Retained Earnings -$176.8M -$163.4M -$85.63M
YoY Change 90.86%
Common Stock $225.3M $222.9M $183.4M
YoY Change 21.58%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $48.43M $59.49M $97.73M
YoY Change
Total Liabilities & Shareholders Equity $99.97M $115.4M $186.5M
YoY Change -28.6% -38.13% 2419.97%

Cashflow Statement

Concept 2021 Q1 2020 Q4 2019 Q4
OPERATING ACTIVITIES
Net Income -$13.40M -$19.23M -$26.06M
YoY Change -33.76% -26.21% -15.66%
Depreciation, Depletion And Amortization $260.0K $470.0K $650.0K
YoY Change -58.73% -27.69% 38.3%
Cash From Operating Activities -$14.46M -$14.04M -$22.17M
YoY Change -50.46% -36.67% -4.23%
INVESTING ACTIVITIES
Capital Expenditures $0.00 -$30.00K -$180.0K
YoY Change -100.0% -83.33% -90.11%
Acquisitions
YoY Change
Other Investing Activities $1.460M $1.470M $70.00K
YoY Change 2820.0% 2000.0%
Cash From Investing Activities $1.462M $1.440M -$100.0K
YoY Change -207.82% -1540.0% -94.51%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 27.00K 160.0K 140.0K
YoY Change 2600.0% 14.29% -99.44%
NET CHANGE
Cash From Operating Activities -14.46M -14.04M -22.17M
Cash From Investing Activities 1.462M 1.440M -100.0K
Cash From Financing Activities 27.00K 160.0K 140.0K
Net Change In Cash -12.97M -12.44M -22.13M
YoY Change -57.53% -43.79% -2376190656512001000.0%
FREE CASH FLOW
Cash From Operating Activities -$14.46M -$14.04M -$22.17M
Capital Expenditures $0.00 -$30.00K -$180.0K
Free Cash Flow -$14.46M -$14.01M -$21.99M
YoY Change -52.74% -36.29% 3.09%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 dei Trading Symbol
TradingSymbol
CYCN
CY2020 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
No
CY2020 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2020 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
true
CY2020 dei Entity Ex Transition Period
EntityExTransitionPeriod
false
CY2020 dei Entity Shell Company
EntityShellCompany
false
CY2020Q2 dei Entity Public Float
EntityPublicFloat
160200000
CY2021Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
34054704
CY2020 dei Entity Central Index Key
EntityCentralIndexKey
0001755237
CY2020 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2020
CY2020 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2020 dei Amendment Flag
AmendmentFlag
false
CY2020 dei Document Annual Report
DocumentAnnualReport
true
CY2020 dei Document Transition Report
DocumentTransitionReport
false
CY2020 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
83-1895370
CY2020 dei Entity File Number
EntityFileNumber
001-38787
CY2020 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
MA
CY2020 dei Entity Address Address Line1
EntityAddressAddressLine1
245 First Street
CY2020 dei Entity Address Address Line2
EntityAddressAddressLine2
18th Floor
CY2020 dei Entity Address City Or Town
EntityAddressCityOrTown
Cambridge
CY2020 dei Entity Address State Or Province
EntityAddressStateOrProvince
MA
CY2020 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
02142
CY2020 dei City Area Code
CityAreaCode
857
CY2020 dei Local Phone Number
LocalPhoneNumber
327-8778
CY2020 dei Security12b Title
Security12bTitle
Common Stock, no par value
CY2020 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
54395000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
94895000
CY2020Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
127000
CY2019Q4 us-gaap Accounts Receivable Related Parties Current
AccountsReceivableRelatedPartiesCurrent
1474000
CY2020Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
816000
CY2019Q4 us-gaap Prepaid Expense Current
PrepaidExpenseCurrent
1966000
CY2020Q4 us-gaap Other Assets Current
OtherAssetsCurrent
3163000
CY2019Q4 us-gaap Other Assets Current
OtherAssetsCurrent
2862000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
58501000
CY2019Q4 us-gaap Assets Current
AssetsCurrent
101197000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
3837000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
4991000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
6865000
CY2019Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
11613000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
43402000
CY2019Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
68137000
CY2020Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
2773000
CY2019Q4 us-gaap Other Assets Noncurrent
OtherAssetsNoncurrent
540000
CY2020Q4 us-gaap Assets
Assets
115378000
CY2019Q4 us-gaap Assets
Assets
186478000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
1149000
CY2019Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
3230000
CY2020Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
286000
CY2019Q4 us-gaap Accounts Payable Related Parties Current
AccountsPayableRelatedPartiesCurrent
81000
CY2020Q4 cycn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
1421000
CY2019Q4 cycn Accrued Research And Development Current
AccruedResearchAndDevelopmentCurrent
2198000
CY2020Q4 cycn Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
7294000
CY2019Q4 cycn Accrued Expenses And Other Liabilities Current
AccruedExpensesAndOtherLiabilitiesCurrent
9320000
CY2020Q4 us-gaap Notes Payable Current
NotesPayableCurrent
3509000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3293000
CY2019Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3420000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
16952000
CY2019Q4 us-gaap Liabilities Current
LiabilitiesCurrent
18249000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
38933000
CY2019Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
70500000
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2019Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-163429000
CY2019Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-85627000
CY2020Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
222949000
CY2019Q4 us-gaap Additional Paid In Capital Common Stock
AdditionalPaidInCapitalCommonStock
183376000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-27000
CY2019Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-20000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
59493000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
97729000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
115378000
CY2019Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
186478000
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2019Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2019Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
400000000
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
34047300
CY2019Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
27598133
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
34047300
CY2019Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
27598133
CY2019 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
4507000
CY2020 us-gaap General And Administrative Expense
GeneralAndAdministrativeExpense
28816000
CY2020 cycn Gain Loss On Modification Of Lease
GainLossOnModificationOfLease
1669000
CY2020 us-gaap Operating Expenses
OperatingExpenses
83561000
CY2019 us-gaap Operating Expenses
OperatingExpenses
129544000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-81265000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
1524000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6888000
CY2020 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
1542000
CY2019 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
173000
CY2020 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-159000
CY2019 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-751000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
14992000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
19631000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
18000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-6715000
CY2020 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
24250000
CY2019 us-gaap Proceeds From Issuance Of Private Placement
ProceedsFromIssuanceOfPrivatePlacement
175000000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-125037000
CY2020 cycn Sublease Termination Income Loss Net
SubleaseTerminationIncomeLossNet
2875000
CY2020 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
588000
CY2019 us-gaap Investment Income Nonoperating
InvestmentIncomeNonoperating
2029000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-77802000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-123008000
CY2020 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-2.56
CY2019 us-gaap Earnings Per Share Basic And Diluted
EarningsPerShareBasicAndDiluted
-4.49
CY2020 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
30403000
CY2019 us-gaap Weighted Average Number Of Share Outstanding Basic And Diluted
WeightedAverageNumberOfShareOutstandingBasicAndDiluted
27380000
CY2020 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-7000
CY2019 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-20000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-7000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax
OtherComprehensiveIncomeLossNetOfTax
-20000
CY2020 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-77809000
CY2019 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-123028000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-10445000
CY2019 cycn Contributed Capital
ContributedCapital
38687000
CY2019 cycn Share Based Compensation Upon Separation
ShareBasedCompensationUponSeparation
3989000
CY2019 cycn Adjustments Upon Separation
AdjustmentsUponSeparation
7752000
CY2019 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
164622000
CY2019 cycn Stock Issued During Period Value Exercise Of Stock Options Restricted Stock Units And Employee Stock Purchase Plans
StockIssuedDuringPeriodValueExerciseOfStockOptionsRestrictedStockUnitsAndEmployeeStockPurchasePlans
510000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
15642000
CY2020 us-gaap Stock Issued During Period Shares New Issues
StockIssuedDuringPeriodSharesNewIssues
24250
CY2020 cycn Stock Issued During Period Value Exercise Of Stock Options Restricted Stock Units And Employee Stock Purchase Plans
StockIssuedDuringPeriodValueExerciseOfStockOptionsRestrictedStockUnitsAndEmployeeStockPurchasePlans
331000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
14992000
CY2020 us-gaap Profit Loss
ProfitLoss
-77802000
CY2019 us-gaap Profit Loss
ProfitLoss
-123008000
CY2020 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2297000
CY2019 us-gaap Depreciation And Amortization
DepreciationAndAmortization
2700000
CY2020 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
-1346000
CY2019 us-gaap Increase Decrease In Accounts Receivable Related Parties
IncreaseDecreaseInAccountsReceivableRelatedParties
1474000
CY2020 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
-1150000
CY2019 us-gaap Increase Decrease In Prepaid Expense
IncreaseDecreaseInPrepaidExpense
1099000
CY2020 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
55000
CY2019 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
115000
CY2020 cycn Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
2598000
CY2019 cycn Increase Decrease In Operating Lease Assets
IncreaseDecreaseInOperatingLeaseAssets
-3129000
CY2020 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
888000
CY2019 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
515000
CY2020 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-1301000
CY2019 us-gaap Increase Decrease In Accounts Payable Trade
IncreaseDecreaseInAccountsPayableTrade
-331000
CY2020 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
205000
CY2019 us-gaap Increase Decrease In Accounts Payable Related Parties
IncreaseDecreaseInAccountsPayableRelatedParties
81000
CY2020 cycn Increase Decrease In Accrued Research And Development
IncreaseDecreaseInAccruedResearchAndDevelopment
-776000
CY2019 cycn Increase Decrease In Accrued Research And Development
IncreaseDecreaseInAccruedResearchAndDevelopment
-3064000
CY2020 cycn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
-2692000
CY2019 cycn Increase Decrease In Operating Lease Liabilities
IncreaseDecreaseInOperatingLeaseLiabilities
2655000
CY2020 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1983000
CY2019 us-gaap Increase Decrease In Other Accounts Payable And Accrued Liabilities
IncreaseDecreaseInOtherAccountsPayableAndAccruedLiabilities
-1556000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-72490000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-102215000
CY2019 us-gaap Payments Of Stock Issuance Costs
PaymentsOfStockIssuanceCosts
10378000
CY2020 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
331000
CY2019 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
510000
CY2020 us-gaap Proceeds From Notes Payable
ProceedsFromNotesPayable
3509000
CY2019 us-gaap Proceeds From Contributed Capital
ProceedsFromContributedCapital
46439000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
28090000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
211571000
CY2020 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-7000
CY2019 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-20000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-44389000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
102621000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
102621000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
58232000
CY2020 cycn Payments For Lease Modification Termination Fee And Other Initial Direct Costs
PaymentsForLeaseModificationTerminationFeeAndOtherInitialDirectCosts
6507000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
823000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
3837000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents
RestrictedCashAndCashEquivalents
7726000
CY2020 us-gaap Use Of Estimates
UseOfEstimates
<p style="margin-top:12pt;margin-bottom:0pt;text-indent:0%;font-weight:bold;font-size:10pt;font-family:Times New Roman;font-style:normal;text-transform:none;font-variant: normal;">Use of Estimates</p> <p style="margin-top:12pt;margin-bottom:0pt;text-indent:6.67%;font-size:10pt;font-family:Times New Roman;font-weight:normal;font-style:normal;text-transform:none;font-variant: normal;">The preparation of consolidated and combined financial statements in accordance with U.S.&#160;GAAP requires the Company&#8217;s management to make estimates and judgments that may affect the reported amounts of assets and liabilities and disclosure of contingent assets and liabilities at the date of the consolidated and combined financial statements, and the amounts of expenses during the reported periods. On an ongoing basis, the Company&#8217;s management evaluates its estimates, judgments and methodologies. Significant estimates and assumptions in the consolidated and combined financial statements include those related to allocations of expenses, assets and liabilities from Ironwood&#8217;s historical financial statements for the periods prior to the Separation, impairment of long-lived assets, income taxes, including the valuation allowance for deferred tax assets, research and development expenses, contingencies and share-based compensation. The Company bases its estimates on historical experience and on various other assumptions that are believed to be reasonable, the results of which form the basis for making judgments about the carrying values of assets and liabilities. Actual results may differ materially from these estimates under different assumptions or conditions. Changes in estimates are reflected in reported results in the period in which they become known.</p>
CY2020Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
176000
CY2020 us-gaap Health Care Trust Fund Description
HealthCareTrustFundDescription
We have initiated our CY6463 Phase 2 clinical trial in adult participants with MELAS. In the coming months, we will use the findings of the translational pharmacology study, in addition to observations from the first-in-human Phase 1 study, to inform further clinical development activities, including the initiation of a planned Phase 2 clinical trial in ADv in mid-2021, as well as explore other potential indications. The ADv study will be supported in part by a grant from the Alzheimer’s Association’s Part the Cloud-Gates Partnership Grant Program, which provides Cyclerion with $2 million of funding over two years.
CY2019Q2 cycn Dividends Common Stock Stock Ratio
DividendsCommonStockStockRatio
0.1
CY2020 us-gaap Number Of Reportable Segments
NumberOfReportableSegments
1
CY2020Q4 us-gaap Cash
Cash
0
CY2020Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
3800000
CY2019Q4 us-gaap Security Deposit Liability
SecurityDepositLiability
7700000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsNoncurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:NoncurrentAssets
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
2700000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Current Asset Statement Of Financial Position Extensible List
RestrictedCashAndCashEquivalentsCurrentAssetStatementOfFinancialPositionExtensibleList
us-gaap:OtherAssetsCurrent
CY2020 us-gaap Lease Practical Expedients Package
LeasePracticalExpedientsPackage
true
CY2020Q4 us-gaap Short Term Borrowings
ShortTermBorrowings
3500000
CY2020 cycn Initial Term Of Agreement
InitialTermOfAgreement
P2Y
CY2020 cycn Development Agreement Renewal Period
DevelopmentAgreementRenewalPeriod
P1Y
CY2020 cycn Development Agreement Period For Notification Of Cancellation
DevelopmentAgreementPeriodForNotificationOfCancellation
P6M
CY2020Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Income Tax Examination Penalties And Interest Accrued
IncomeTaxExaminationPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
17152000
CY2019Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
33215000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
10287000
CY2019Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
21602000
CY2020Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
1720000
CY2019Q4 us-gaap Accrued Bonuses Current
AccruedBonusesCurrent
3767000
CY2020Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
514000
CY2019Q4 us-gaap Accrued Salaries Current
AccruedSalariesCurrent
1730000
CY2020Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
555000
CY2019Q4 us-gaap Accrued Vacation Current
AccruedVacationCurrent
969000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
689000
CY2019Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
441000
CY2020Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
3640000
CY2019Q4 us-gaap Accrued Employee Benefits Current
AccruedEmployeeBenefitsCurrent
2009000
CY2019Q4 us-gaap Other Sundry Liabilities Current
OtherSundryLiabilitiesCurrent
404000
CY2020 us-gaap Lease Cost
LeaseCost
8600000
CY2019 us-gaap Lease Cost
LeaseCost
9300000
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
71266000
CY2020 cycn Decrease In Right Of Use Assets Related To Lease Modification
DecreaseInRightOfUseAssetsRelatedToLeaseModification
27333000
CY2020 cycn Decrease In Operating Lease Liabilities Related To Lease Modification
DecreaseInOperatingLeaseLiabilitiesRelatedToLeaseModification
29002000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
7411000
CY2019 us-gaap Operating Lease Payments
OperatingLeasePayments
3288000
CY2019 cycn Operating Lease Tenant Improvements Received
OperatingLeaseTenantImprovementsReceived
2289000
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P8Y6M0D
CY2019Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P9Y6M0D
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.061
CY2019Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.109
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
5742000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
5908000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
6080000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
6256000
CY2020 cycn Provision For Income Taxes
ProvisionForIncomeTaxes
0
CY2019 cycn Provision For Income Taxes
ProvisionForIncomeTaxes
0
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-77884000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-122437000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
82000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
31000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-77802000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
6438000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
24047000
CY2020Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
54471000
CY2020Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
12245000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
42226000
CY2019Q1 cycn Rentable Square Feet Of Short Term Sublease Agreement
RentableSquareFeetOfShortTermSubleaseAgreement
24000
CY2019Q1 cycn Sublease Initial Term Of Contract
SubleaseInitialTermOfContract
P1M
CY2019Q1 us-gaap Lessee Operating Sublease Existence Of Option To Extend
LesseeOperatingSubleaseExistenceOfOptionToExtend
true
CY2019Q1 cycn Subleased Term
SubleasedTerm
P1M15D
CY2019Q1 cycn Operating Lease Sublease Expense
OperatingLeaseSubleaseExpense
200000
CY2019 cycn Operating Lease Sublease Expense
OperatingLeaseSubleaseExpense
9300000
CY2019Q4 cycn Rentable Square Feet Sublease To Third Party
RentableSquareFeetSubleaseToThirdParty
15700
CY2020Q3 cycn Rentable Square Feet Sublease To Third Party
RentableSquareFeetSubleaseToThirdParty
15700
CY2020Q3 cycn Sublease Termination Agreement Estimated Fair Value Of Rooms
SubleaseTerminationAgreementEstimatedFairValueOfRooms
1500000
CY2020Q3 cycn Sublease Termination Agreement Estimated Fair Value Of Services
SubleaseTerminationAgreementEstimatedFairValueOfServices
2900000
CY2020Q3 cycn Sublease Termination Agreement Prepaid Rooms And Services
SubleaseTerminationAgreementPrepaidRoomsAndServices
4400000
CY2020 cycn Gross Sublease Income Net Of Rent Expense
GrossSubleaseIncomeNetOfRentExpense
1500000
CY2019 cycn Gross Sublease Income Net Of Rent Expense
GrossSubleaseIncomeNetOfRentExpense
400000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Plan Modification Number Of Employees Affected
ShareBasedCompensationArrangementByShareBasedPaymentAwardPlanModificationNumberOfEmployeesAffected
143
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
14992000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
19630000
CY2020 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2019 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Vested Number Of Shares
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsVestedNumberOfShares
0
CY2020 cycn Share Based Compensation Expense
ShareBasedCompensationExpense
100000
CY2019 cycn Share Based Compensation Expense
ShareBasedCompensationExpense
100000
CY2020 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
100000
CY2019 us-gaap Deferred Compensation Arrangement With Individual Allocated Share Based Compensation Expense
DeferredCompensationArrangementWithIndividualAllocatedShareBasedCompensationExpense
100000
CY2020Q4 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Stock Options
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedStockOptions
300000
CY2020 us-gaap Employee Service Share Based Compensation Nonvested Awards Total Compensation Cost Not Yet Recognized Period For Recognition1
EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognizedPeriodForRecognition1
P8Y10M20D
CY2020 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
23473000
CY2020Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
7500000
CY2019Q4 us-gaap Tax Credit Carryforward Amount
TaxCreditCarryforwardAmount
3800000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-122406000
CY2020 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-16338000
CY2019 us-gaap Income Tax Reconciliation Income Tax Expense Benefit At Federal Statutory Income Tax Rate
IncomeTaxReconciliationIncomeTaxExpenseBenefitAtFederalStatutoryIncomeTaxRate
-25705000
CY2020 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-5619000
CY2019 us-gaap Income Tax Reconciliation State And Local Income Taxes
IncomeTaxReconciliationStateAndLocalIncomeTaxes
-7548000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
16000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense Share Based Compensation Cost
IncomeTaxReconciliationNondeductibleExpenseShareBasedCompensationCost
55000
CY2020 cycn Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Payment Arrangement Shortfalls Windfalls Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedPaymentArrangementShortfallsWindfallsAmount
1047000
CY2019 cycn Effective Income Tax Rate Reconciliation Nondeductible Expense Share Based Payment Arrangement Shortfalls Windfalls Amount
EffectiveIncomeTaxRateReconciliationNondeductibleExpenseShareBasedPaymentArrangementShortfallsWindfallsAmount
273000
CY2020 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
-94000
CY2019 us-gaap Income Tax Reconciliation Nondeductible Expense
IncomeTaxReconciliationNondeductibleExpense
1528000
CY2020 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
2469000
CY2019 us-gaap Income Tax Reconciliation Tax Credits
IncomeTaxReconciliationTaxCredits
4875000
CY2019 us-gaap Income Tax Reconciliation Disposition Of Business
IncomeTaxReconciliationDispositionOfBusiness
9800000
CY2020 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-16000
CY2019 us-gaap Income Tax Reconciliation Other Adjustments
IncomeTaxReconciliationOtherAdjustments
-6000
CY2019 us-gaap Income Tax Reconciliation Change In Deferred Tax Assets Valuation Allowance
IncomeTaxReconciliationChangeInDeferredTaxAssetsValuationAllowance
26478000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
27007000
CY2019Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
17228000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
7185000
CY2019Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards
DeferredTaxAssetsTaxCreditCarryforwards
3733000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
5890000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
3593000
CY2020Q4 cycn Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
11536000
CY2019Q4 cycn Deferred Tax Assets Operating Lease Liabilities
DeferredTaxAssetsOperatingLeaseLiabilities
20195000
CY2020Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1362000
CY2019Q4 us-gaap Deferred Tax Assets Property Plant And Equipment
DeferredTaxAssetsPropertyPlantAndEquipment
1954000
CY2020Q4 cycn Deferred Tax Assets Capitalized Research And Development Costs
DeferredTaxAssetsCapitalizedResearchAndDevelopmentCosts
12684000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
518000
CY2019Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
1561000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
66182000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
13060000
CY2019Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
18615000
CY2020Q4 cycn Net Deferred Assets Liabilities Before Valuation Allowance
NetDeferredAssetsLiabilitiesBeforeValuationAllowance
53122000
CY2019Q4 cycn Net Deferred Assets Liabilities Before Valuation Allowance
NetDeferredAssetsLiabilitiesBeforeValuationAllowance
29649000
CY2019Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
48264000
CY2020Q4 cycn Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
11857000
CY2019Q4 cycn Deferred Tax Liabilities Operating Lease Right Of Use Assets
DeferredTaxLiabilitiesOperatingLeaseRightOfUseAssets
18615000
CY2020Q4 cycn Deferred Tax Liability Prepaid Sublease Termination
DeferredTaxLiabilityPrepaidSubleaseTermination
1203000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
53122000
CY2019Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
29649000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
0
CY2020Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2020Q4 us-gaap Defined Contribution Plan Type Extensible List
DefinedContributionPlanTypeExtensibleList
us-gaap:DefinedContributionPlanTypeExtensibleList
CY2020 us-gaap Defined Contribution Plan Employer Matching Contribution Percent Of Match
DefinedContributionPlanEmployerMatchingContributionPercentOfMatch
0.75
CY2020 cycn Defined Contribution Plan Employer Matching Contribution Maximum
DefinedContributionPlanEmployerMatchingContributionMaximum
6000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
500000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
600000

Files In Submission

Name View Source Status
0001564590-21-008434-index-headers.html Edgar Link pending
0001564590-21-008434-index.html Edgar Link pending
0001564590-21-008434.txt Edgar Link pending
0001564590-21-008434-xbrl.zip Edgar Link pending
cycn-10k_20201231.htm Edgar Link pending
cycn-20201231.xml Edgar Link completed
cycn-20201231.xsd Edgar Link pending
cycn-20201231_cal.xml Edgar Link unprocessable
cycn-20201231_def.xml Edgar Link unprocessable
cycn-20201231_lab.xml Edgar Link unprocessable
cycn-20201231_pre.xml Edgar Link unprocessable
cycn-ex211_11.htm Edgar Link pending
cycn-ex231_10.htm Edgar Link pending
cycn-ex311_9.htm Edgar Link pending
cycn-ex312_8.htm Edgar Link pending
cycn-ex321_6.htm Edgar Link pending
cycn-ex322_7.htm Edgar Link pending
cycn-ex41_12.htm Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
guuxs1oeut4v000001.jpg Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending